Peginterferon α-2b Injection for Hydroxyurea Resistant or Intolerant ET
Peginterferon α-2b Injection for Hydroxyurea Resistant or Intolerant ET
Recruiting · NCT06552429 · Registry updated 2025-11-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Peginterferon α-2b Injection for Hydroxyurea Resistant or Intolerant ET | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, blood coagulation disease, blood platelet disease, bone marrow disorder, essential thrombocythemia, hematologic disorder, hemorrhagic disease, thrombocytosis disease | Recruiting | Phase 2 | 2025-11-17 | NCT06552429 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Xiamen Amoytop Biotech Co., Ltd. | 11 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Harbin First Hospital | Harbin | China | 3 |
| Henan Cancer Hospital | Henan | China | 6 |
| Nanfang Hospital, Southern Medical University | Guangzhou | China | 15 |
| Peking Union Hospital, Chinese Academy of Medical Sciences | Beijing | China | 1 |
| Peking University People's Hospital | Beijing | China | 68 |
| Ruijin Hospital, Shanghai Jiao Tong University School of Medicine | Shanghai | China | 23 |
| The First Affiliated Hospital of Zhejiang University School of Medicine | Zhejiang | China | 3 |
| Union Hospital affiliated to Fujian Medical University | Fujian | China | 1 |